Michael Robin joined Acelot in 2026 as Vice President, Program Management & Operations. With 15+ years in the biopharmaceutical industry, he has led end-to-end program and portfolio execution with expertise in strategic planning, operational governance, and cross-functional program leadership.

Prior to his work at Acelot, Michael served as Vice President, Head of Program Management & Operations at Roivant Sciences and held multiple leadership roles at Nektar Therapeutics, advancing to Vice President, Program Management, where he led portfolio execution and governance across a $400M annual R&D budget. Most recently, as a strategic consultant, he served as Chief of Staff for Development at Tenaya Therapeutics and also led Olema Oncology’s KAT6 program through IND submission and Phase 1 initiation.

Michael holds a B.S. in Biochemistry from the University of California, Los Angeles (UCLA).